These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8862292)

  • 1. Reproducibility of regional brain metabolic responses to lorazepam.
    Wang GJ; Volkow ND; Overall J; Hitzemann RJ; Pappas N; Pascani K; Fowler JS
    J Nucl Med; 1996 Oct; 37(10):1609-13. PubMed ID: 8862292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measuring reproducibility of regional brain metabolic responses to lorazepam using statistical parametric maps.
    Wang GJ; Volkow ND; Levy AV; Felder CA; Fowler JS; Pappas NR; Hitzemann RJ; Wong CT
    J Nucl Med; 1999 May; 40(5):715-20. PubMed ID: 10319741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of gender difference in regional brain metabolic responses to lorazepam.
    Wang GJ; Volkow ND; Fowler JS; Hitzemann RJ; Pappas NR; Netusil N
    Psychiatry Res; 1998 Apr; 82(1):37-46. PubMed ID: 9645549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional brain metabolism during alcohol intoxication.
    Wang GJ; Volkow ND; Franceschi D; Fowler JS; Thanos PK; Scherbaum N; Pappas N; Wong CT; Hitzemann RJ; Felder CA
    Alcohol Clin Exp Res; 2000 Jun; 24(6):822-9. PubMed ID: 10888070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased cerebral response to inhibitory neurotransmission in alcoholics.
    Volkow ND; Wang GJ; Hitzemann R; Fowler JS; Wolf AP; Pappas N; Biegon A; Dewey SL
    Am J Psychiatry; 1993 Mar; 150(3):417-22. PubMed ID: 8382010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced sensitivity to benzodiazepines in active cocaine-abusing subjects: a PET study.
    Volkow ND; Wang GJ; Fowler JS; Hitzemann R; Gatley SJ; Dewey SS; Pappas N
    Am J Psychiatry; 1998 Feb; 155(2):200-6. PubMed ID: 9464198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depression of thalamic metabolism by lorazepam is associated with sleepiness.
    Volkow ND; Wang GJ; Hitzemann R; Fowler JS; Pappas N; Lowrimore P; Burr G; Pascani K; Overall J; Wolf AP
    Neuropsychopharmacology; 1995 Apr; 12(2):123-32. PubMed ID: 7779240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional brain metabolic response to lorazepam in alcoholics during early and late alcohol detoxification.
    Volkow ND; Wang GJ; Overall JE; Hitzemann R; Fowler JS; Pappas N; Frecska E; Piscani K
    Alcohol Clin Exp Res; 1997 Oct; 21(7):1278-84. PubMed ID: 9347090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The thalamus as the generator and modulator of EEG alpha rhythm: a combined PET/EEG study with lorazepam challenge in humans.
    Schreckenberger M; Lange-Asschenfeldt C; Lochmann M; Mann K; Siessmeier T; Buchholz HG; Bartenstein P; Gründer G
    Neuroimage; 2004 Jun; 22(2):637-44. PubMed ID: 15193592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral glucose metabolism during pharmacologic studies: test-retest under placebo conditions.
    Schmidt ME; Ernst M; Matochik JA; Maisog JM; Pan BS; Zametkin AJ; Potter WZ
    J Nucl Med; 1996 Jul; 37(7):1142-9. PubMed ID: 8965185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute effect of 3-(4-acetamido)-butyrril-lorazepam (DDS2700) on brain function assessed by PET at rest and during attentive tasks.
    Moresco RM; Tettamanti M; Gobbo C; Del Sole A; Ravasi L; Messa C; Paulesu E; Lucignani G; Perani D; Fazio F
    Nucl Med Commun; 2001 Apr; 22(4):399-404. PubMed ID: 11338050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional brain metabolic response to lorazepam in subjects at risk for alcoholism.
    Volkow ND; Wang GJ; Begleiter H; Hitzemann R; Pappas N; Burr G; Pascani K; Wong C; Fowler JS; Wolf AP
    Alcohol Clin Exp Res; 1995 Apr; 19(2):510-6. PubMed ID: 7625590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender differences in cerebellar metabolism: test-retest reproducibility.
    Volkow ND; Wang GJ; Fowler JS; Hitzemann R; Pappas N; Pascani K; Wong C
    Am J Psychiatry; 1997 Jan; 154(1):119-21. PubMed ID: 8988972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positron emission tomography assessment of effects of benzodiazepines on regional glucose metabolic rate in patients with anxiety disorder.
    Buchsbaum MS; Wu J; Haier R; Hazlett E; Ball R; Katz M; Sokolski K; Lagunas-Solar M; Langer D
    Life Sci; 1987 Jun; 40(25):2393-400. PubMed ID: 2884547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reproducibility of cerebral glucose utilization measured by PET and the [18F]-2-fluoro-2-deoxy-d-glucose method in resting, healthy human subjects.
    Maquet P; Dive D; Salmon E; von Frenckel R; Franck G
    Eur J Nucl Med; 1990; 16(4-6):267-73. PubMed ID: 2351175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional brain glucose metabolism after acute alpha 2-blockade by idazoxan.
    Schmidt ME; Matochik JA; Risinger RC; Schouten JL; Zametkin AJ; Cohen RM; Potter WZ
    Clin Pharmacol Ther; 1995 Jun; 57(6):684-95. PubMed ID: 7781269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of regional rate constants from dynamic FDG-PET studies in Parkinson's disease.
    Piert M; Koeppe RA; Giordani B; Minoshima S; Kuhl DE
    J Nucl Med; 1996 Jul; 37(7):1115-22. PubMed ID: 8965180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional cerebral function determined by FDG-PET in healthy volunteers: normal patterns and changes with age.
    Loessner A; Alavi A; Lewandrowski KU; Mozley D; Souder E; Gur RE
    J Nucl Med; 1995 Jul; 36(7):1141-9. PubMed ID: 7790936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Independent thallium-201 accumulation and fluorine-18-fluorodeoxyglucose metabolism in glioma.
    Oriuchi N; Tomiyoshi K; Inoue T; Ahmad K; Sarwar M; Tokunaga M; Suzuki H; Watanabe N; Hirano T; Horikoshi S; Shibasaki T; Tamura M; Endo K
    J Nucl Med; 1996 Mar; 37(3):457-62. PubMed ID: 8772644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorine-18-fluorodeoxyglucose PET to determine regional cerebral glucose utilization: a re-examination.
    Schmidt KC; Lucignani G; Sokoloff L
    J Nucl Med; 1996 Feb; 37(2):394-9. PubMed ID: 8667082
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.